…
Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia. It operates through Visionflex and Corporate head office segments. The company offers Virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. It serves primary health networks, local health districts, residential aged care facilities, aboriginal community-controlled health organisations, and private healthcare organisations. The company was formerly known as 1st Group Limited and changed its name to Visionflex Group Limited in November 2023. Visionflex Group Limited was incorporated in 2009 and is based in Warriewood, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Publicly available information on Visionflex Group Ltd (ASX: VFX) is limited and company disclosures and analyst coverage are sparse, so a definitive description of its core business is not possible from open sources. Prospective investors should review the company's filings for details; long-term attractiveness would depend on demonstrated revenue sustainability, scalable operations and a defensible market position.
Key investment risks include limited public disclosure and liquidity, execution and operational risk typical of small listed companies, and potential need for additional financing.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -0.60M | -3.73M | -2.15M | -3.90M | -6.80M |
| Net income | -0.06M | -3.19M | -1.83M | -3.66M | -6.82M |
| Selling general administrative | - | 6.75M | 4.95M | 6.23M | 7.86M |
| Gross profit | -0.89M | -2.42M | 3.94M | 3.41M | 4.83M |
| Reconciled depreciation | - | - | 0.02M | 0.03M | 0.03M |
| Ebit | -2.11M | -3.44M | - | - | - |
| Ebitda | -2.06M | -3.37M | - | - | - |
| Depreciation and amortization | 0.06M | 0.07M | - | - | - |
| Operating income | -2.11M | -3.90M | -1.64M | -3.58M | -3.63M |
| Other operating expenses | 6.25M | 8.09M | - | - | - |
| Interest expense | 0.16M | 0.29M | 0.81M | 0.31M | 0.34M |
| Tax provision | - | -0.53M | -0.62M | -0.62M | 0.02M |
| Interest income | - | 0.29M | 0.00M | 0.00M | 0.00M |
| Net interest income | - | - | -0.81M | -0.31M | -0.34M |
| Extraordinary items | - | 0.11M | - | - | - |
| Income tax expense | -0.54M | -0.53M | - | - | - |
| Total revenue | 4.14M | 4.19M | 6.65M | 4.47M | 4.83M |
| Total operating expenses | 1.22M | 1.48M | - | - | - |
| Cost of revenue | 5.02M | 6.61M | 2.71M | 1.06M | - |
| Total other income expense net | 1.52M | 0.17M | 0.30M | -0.01M | -2.82M |
| Net income from continuing ops | - | - | -1.53M | -3.28M | -6.82M |
| Net income applicable to common shares | - | -3.09M | - | - | - |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 3.09M | 3.39M | 2.88M | 3.36M | 4.18M |
| Intangible assets | 0.01M | 0.00M | 0.01M | 0.01M | 0.01M |
| Other current assets | 0.11M | - | 0.01M | 0.02M | 0.19M |
| Total liab | 3.11M | 5.22M | 10.99M | 10.10M | 8.07M |
| Total stockholder equity | -0.01M | -1.82M | -8.11M | -6.74M | -3.89M |
| Other current liab | 0.85M | - | 1.41M | 0.25M | - |
| Common stock | 51.22M | 48.98M | - | - | - |
| Capital stock | - | - | 40.10M | 40.27M | 39.29M |
| Retained earnings | -54.72M | -50.80M | -51.57M | -49.73M | -46.01M |
| Cash | 1.62M | - | 1.16M | 1.44M | 2.01M |
| Cash and equivalents | - | 1.89M | - | - | - |
| Total current liabilities | 2.86M | 3.68M | 4.01M | 4.04M | 3.95M |
| Current deferred revenue | 1.43M | - | - | - | - |
| Net debt | -1.04M | - | 5.67M | 4.61M | 1.99M |
| Short term debt | 0.43M | 0.97M | - | - | - |
| Short long term debt | - | - | 0.00M | 0.01M | - |
| Short long term debt total | 0.58M | - | - | - | - |
| Property plant equipment | - | 0.13M | - | - | - |
| Total current assets | 2.99M | 3.26M | 2.82M | 3.33M | 4.12M |
| Net receivables | 1.02M | 0.38M | 0.30M | 0.52M | 0.39M |
| Long term debt | - | 1.50M | 6.83M | 6.05M | 4.00M |
| Inventory | 0.23M | 0.26M | 0.65M | 0.60M | 0.57M |
| Accounts payable | 0.16M | - | 0.47M | 1.05M | 1.42M |
| Accumulated other comprehensive income | 3.48M | - | - | - | - |
| Non current assets total | 0.10M | - | 0.06M | 0.03M | 0.06M |
| Long term debt total | - | 1.50M | - | - | - |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | - | 0.28M | 0.72M | -0.02M |
| Total cashflows from investing activities | -0.02M | -0.03M | - | - | - |
| Total cash from financing activities | 1.02M | 3.92M | 0.80M | 2.36M | 4.59M |
| Net income | -0.06M | -3.21M | -1.83M | -3.66M | -6.82M |
| Change in cash | -0.27M | 0.73M | -0.28M | -0.56M | 1.77M |
| Begin period cash flow | 1.89M | 1.16M | 1.44M | 2.01M | 0.24M |
| End period cash flow | 1.62M | 1.89M | 1.16M | 1.44M | 2.01M |
| Total cash from operating activities | -1.26M | -3.16M | - | - | - |
| Issuance of capital stock | - | - | 0.02M | 0.91M | 3.84M |
| Depreciation | 0.06M | 0.07M | - | - | - |
| Change to inventory | 0.03M | 0.39M | - | - | - |
| Change to account receivables | -0.05M | -0.04M | - | - | - |
| Other cashflows from financing activities | -0.09M | - | - | - | - |
| Capital expenditures | 0.01M | 0.03M | 0.02M | 0.03M | 0.02M |
| Change in working capital | -0.22M | -0.68M | - | - | - |
| Other non cash items | -1.04M | 0.65M | - | - | - |
| Free cash flow | -1.27M | -3.19M | -1.38M | -3.68M | -2.82M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VFX Visionflex Group Ltd |
- -% |
0.04 | - | - | 0.83 | 31.44 | 0.59 | -12.21 |
| PME Pro Medicus Ltd |
-4.52 2.18% |
202.79 | 81.98 | 106.38 | 83.13 | 43.70 | 74.38 | 95.34 |
| 4DX 4DMEDICAL Ltd |
-0.06 2.53% |
2.31 | - | - | 205.57 | 8.53 | 170.03 | -7.29 |
| CGS Cogstate Ltd |
0.12 3.30% |
3.76 | 33.80 | 27.86 | 9.59 | 6.95 | 6.35 | 19.27 |
| AYA ARTRYA Ltd |
-0.14 3.91% |
3.44 | - | - | 20505.14 | 7.00 | 16927.51 | 0.33 |
Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia. It operates through Visionflex and Corporate head office segments. The company offers Virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. It serves primary health networks, local health districts, residential aged care facilities, aboriginal community-controlled health organisations, and private healthcare organisations. The company was formerly known as 1st Group Limited and changed its name to Visionflex Group Limited in November 2023. Visionflex Group Limited was incorporated in 2009 and is based in Warriewood, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Joshua Mundey | Chief Executive Officer | NA |
| Mr. James Aulsebrook | Chief Financial Officer | NA |
| Michael Kafruni | Chief Operating Officer | NA |
| Mr. Ben Robinson | Head of Growth | NA |
| Mr. Michael John Harman | Head of Visionflex | NA |
| Ms. Elizabeth Spooner | Company Secretary | NA |
| Ms. Maria Clemente | Company Secretary | NA |
| Mr. Joshua Mundey | Chief Executive Officer | NA |
| Mr. James Aulsebrook | Chief Financial Officer | NA |
| Michael Kafruni | Chief Operating Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.